Bipin N. Savani

26.7k total citations · 1 hit paper
365 papers, 9.0k citations indexed

About

Bipin N. Savani is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bipin N. Savani has authored 365 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 268 papers in Hematology, 125 papers in Oncology and 91 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bipin N. Savani's work include Hematopoietic Stem Cell Transplantation (214 papers), Acute Myeloid Leukemia Research (112 papers) and Acute Lymphoblastic Leukemia research (85 papers). Bipin N. Savani is often cited by papers focused on Hematopoietic Stem Cell Transplantation (214 papers), Acute Myeloid Leukemia Research (112 papers) and Acute Lymphoblastic Leukemia research (85 papers). Bipin N. Savani collaborates with scholars based in United States, France and Israel. Bipin N. Savani's co-authors include Mohamad Mohty, A. John Barrett, Arnon Nagler, Stephan Mielke, Katayoun Rezvani, Madan Jagasia, Agnes S. M. Yong, A. John Barrett, Paul A. Carpenter and Myriam Labopin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bipin N. Savani

348 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

2012 423 citations Bipin N. Savani, Paul A. Carpenter et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bipin N. Savani United States	51	5.9k	3.0k	2.7k	1.9k	1.1k	365	9.0k
Marcelo C. Pasquini United States	46	5.3k 0.9×	2.3k 0.8×	1.7k 0.6×	1.6k 0.8×	992 0.9×	246	7.6k
Karen K. Ballen United States	45	5.8k 1.0×	2.1k 0.7×	1.9k 0.7×	1.8k 0.9×	1.0k 0.9×	234	8.1k
Ibrahim Yakoub‐Agha France	47	4.7k 0.8×	2.8k 0.9×	1.6k 0.6×	1.3k 0.7×	1.4k 1.3×	407	7.6k
John E. Levine United States	48	6.1k 1.0×	2.2k 0.7×	3.8k 1.4×	1.2k 0.6×	1.4k 1.3×	201	9.5k
Michael B. Maris United States	50	7.8k 1.3×	2.8k 0.9×	2.5k 0.9×	2.3k 1.2×	1.2k 1.1×	173	11.0k
Linda J. Burns United States	46	3.8k 0.6×	3.2k 1.1×	2.8k 1.1×	1.2k 0.7×	532 0.5×	197	7.7k
Mohamed L. Sorror United States	46	8.4k 1.4×	2.8k 1.0×	1.9k 0.7×	2.9k 1.5×	873 0.8×	160	10.9k
Haesook T. Kim United States	52	6.6k 1.1×	2.2k 0.7×	4.5k 1.7×	1.3k 0.7×	958 0.9×	206	10.1k
Madan Jagasia United States	43	5.1k 0.9×	1.6k 0.5×	1.9k 0.7×	1.6k 0.8×	663 0.6×	251	7.2k
Michael A. Pulsipher United States	47	4.5k 0.8×	2.4k 0.8×	1.5k 0.6×	2.1k 1.1×	1.1k 1.0×	253	7.6k

Countries citing papers authored by Bipin N. Savani

Since Specialization

Citations

This map shows the geographic impact of Bipin N. Savani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bipin N. Savani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bipin N. Savani more than expected).

Fields of papers citing papers by Bipin N. Savani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bipin N. Savani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bipin N. Savani. The network helps show where Bipin N. Savani may publish in the future.

Co-authorship network of co-authors of Bipin N. Savani

This figure shows the co-authorship network connecting the top 25 collaborators of Bipin N. Savani. A scholar is included among the top collaborators of Bipin N. Savani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bipin N. Savani. Bipin N. Savani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alsuliman, Tamim, Nour Moukalled, Éolia Brissot, et al.. (2024). Sexual health and emotional wellbeing of patients with haematological malignancies: general review. The Lancet Haematology. 11(10). e770–e779. 3 indexed citations

Smith, Michael A., Rachel Phelan, Ruta Brazauskas, et al.. (2024). Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes. Frontiers in Oncology. 14. 1415984–1415984. 1 indexed citations

Dholaria, Bhagirathbhai, Adetola A. Kassim, Reena Jayani, et al.. (2024). Flat dose intravenous immunoglobulin (IVIG) for primary infection prophylaxis after CAR-T for B-cell non-Hodgkin lymphoma (B-NHL).. Journal of Clinical Oncology. 42(16_suppl). e19004–e19004. 1 indexed citations

Bug, Gesine, Myriam Labopin, Riitta Niittyvuopio, et al.. (2023). Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 58(6). 710–716. 5 indexed citations

Ohmoto, Akihiro, et al.. (2022). Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. Bone Marrow Transplantation. 57(6). 874–880. 10 indexed citations

Abou‐Ismail, Mouhamed Yazan, Raphael Fraser, Leland Metheny, et al.. (2022). Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?. British Journal of Haematology. 197(3). 326–338. 1 indexed citations

Dhakal, Binod, Saurabh Chhabra, Bipin N. Savani, & Mehdi Hamadani. (2021). Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies. British Journal of Haematology. 197(1). 28–40. 7 indexed citations

Labopin, Myriam, Jordi Esteve, Nicolaus Kröger, et al.. (2021). Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT. Bone Marrow Transplantation. 56(10). 2445–2453. 8 indexed citations

Maffini, Enrico, Myriam Labopin, Didier Blaise, et al.. (2020). CD34+ cell dose effects on clinical outcomes after T‐cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT). American Journal of Hematology. 95(8). 892–899. 22 indexed citations

10.

Bazarbachi, Ali, Christoph Schmid, Myriam Labopin, et al.. (2020). Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years. Clinical Cancer Research. 26(24). 6475–6482. 39 indexed citations

11.

Nagler, Arnon, Myriam Labopin, Bhagirathbhai Dholaria, et al.. (2020). Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia. Clinical Cancer Research. 27(3). 843–851. 26 indexed citations

12.

Epperla, Narendranath, Mehdi Hamadani, Tea Reljic, et al.. (2019). Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B‐cell lymphomas in first remission in the rituximab era: A systematic review and meta‐analysis. Cancer. 125(24). 4417–4425. 12 indexed citations

13.

Cohen, Jeffrey A., Laura Baldassari, Harold Atkins, et al.. (2019). Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 25(5). 845–854. 72 indexed citations

14.

Epperla, Narendranath, Kwang Woo Ahn, Philippe Armand, et al.. (2017). Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma. Biology of Blood and Marrow Transplantation. 24(1). 78–85. 7 indexed citations

15.

Labopin, Myriam, Annalisa Ruggeri, Fabio Ciceri, et al.. (2017). Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT. Haematologica. 1 indexed citations

16.

Shouval, Roni, Myriam Labopin, Ron Unger, et al.. (2016). Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study. PLoS ONE. 11(3). e0150637–e0150637. 31 indexed citations

17.

Baron, F, Annalisa Ruggeri, Eric Beohou, et al.. (2016). Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT. Bone Marrow Transplantation. 1 indexed citations

18.

Kennedy, Vanessa E., Bipin N. Savani, John P. Greer, et al.. (2016). Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies. Biology of Blood and Marrow Transplantation. 22(10). 1801–1807. 7 indexed citations

19.

Mielke, Stephan, Aarthi Shenoy, Vicki Fellowes, et al.. (2011). Selectively T Cell-Depleted Allografts from HLA-Matched Sibling Donors Followed by Low-Dose Posttransplantation Immunosuppression to Improve Transplantation Outcome in Patients with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 17(12). 1855–1861. 34 indexed citations

20.

Savani, Bipin N., Michelle L. Griffith, Shubhada Jagasia, & Stephanie J. Lee. (2010). How I treat late effects in adults after allogeneic stem cell transplantation. Blood. 117(11). 3002–3009. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact